Bicara Therapeutics Inc. Common Stock (BCAX) Stock Price History
Historical prices from 2024 to 2026
Loading 10-year price history...
BCAX Historical Performance
Short-Term Returns
BCAX Stock Price Trajectory (2024–2026)
As of May 8, 2026, Bicara Therapeutics Inc. Common Stock (BCAX) trades at $23.09, representing a +94.2% return over the past year. The stock has delivered a -1.4% total return over five years (-0.3% CAGR), reflecting challenging market conditions.
The stock reached its all-time high of $28.09 on November 6, 2024. From this peak, BCAX has corrected -17.8%, currently trading 40% above its 200-day moving average, indicating continued institutional support.
When compared to Healthcare sector peers IMVT (+96.1% 1Y), TGTX (+23.5% 1Y), and ACLX (+117.4% 1Y), BCAX has underperformed the peer group average. Compare BCAX vs IMVT →
BCAX Historical Price Data (2025–2026)
Showing 30 of 414 recordsLoading full history…
| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-07 | 23.57 | 23.76 | 22.60 | 23.09 | 343K | -2.90% |
| 2026-05-06 | 23.18 | 23.80 | 22.82 | 23.78 | 319K | +2.68% |
| 2026-05-05 | 22.97 | 23.19 | 22.22 | 23.16 | 235K | +1.94% |
| 2026-05-04 | 21.63 | 22.94 | 21.63 | 22.72 | 294K | +4.85% |
| 2026-05-01 | 21.60 | 22.46 | 21.37 | 21.67 | 268K | +0.42% |
| 2026-04-30 | 21.27 | 21.84 | 21.07 | 21.58 | 300K | +1.41% |
| 2026-04-29 | 21.54 | 21.82 | 21.18 | 21.28 | 336K | -2.92% |
| 2026-04-28 | 22.51 | 22.76 | 21.82 | 21.92 | 185K | -2.47% |
| 2026-04-27 | 22.54 | 23.29 | 22.23 | 22.48 | 280K | -0.77% |
| 2026-04-24 | 22.44 | 22.88 | 22.27 | 22.65 | 336K | -0.83% |
| 2026-04-23 | 23.57 | 23.99 | 22.66 | 22.84 | 464K | -3.34% |
| 2026-04-22 | 23.28 | 23.66 | 22.96 | 23.63 | 599K | +2.25% |
| 2026-04-21 | 22.69 | 23.50 | 22.61 | 23.11 | 605K | -1.53% |
| 2026-04-20 | 23.64 | 23.91 | 23.35 | 23.47 | 344K | -2.25% |
| 2026-04-17 | 24.25 | 24.25 | 23.74 | 24.01 | 465K | +0.33% |
| 2026-04-16 | 23.53 | 23.93 | 23.11 | 23.93 | 379K | +0.89% |
| 2026-04-15 | 22.98 | 24.00 | 22.54 | 23.72 | 728K | +3.22% |
| 2026-04-14 | 22.24 | 23.15 | 22.24 | 22.98 | 731K | +3.79% |
| 2026-04-13 | 21.25 | 22.25 | 21.09 | 22.14 | 427K | +4.83% |
| 2026-04-10 | 22.00 | 22.00 | 21.08 | 21.12 | 480K | -3.91% |
| 2026-04-09 | 21.43 | 22.01 | 21.20 | 21.98 | 597K | +1.71% |
| 2026-04-08 | 21.84 | 21.85 | 21.51 | 21.61 | 337K | +1.50% |
| 2026-04-07 | 20.98 | 21.84 | 20.57 | 21.29 | 792K | +2.11% |
| 2026-04-06 | 21.58 | 21.63 | 20.62 | 20.85 | 546K | -2.89% |
| 2026-04-02 | 20.05 | 21.50 | 19.92 | 21.47 | 914K | +4.73% |
| 2026-04-01 | 19.98 | 21.05 | 19.78 | 20.50 | 622K | +3.07% |
| 2026-03-31 | 19.41 | 20.03 | 18.90 | 19.89 | 964K | +4.46% |
| 2026-03-30 | 18.13 | 19.41 | 17.63 | 19.04 | 957K | +3.65% |
| 2026-03-27 | 18.65 | 19.00 | 18.05 | 18.37 | 582K | -2.91% |
| 2026-03-26 | 18.57 | 19.11 | 18.30 | 18.92 | 377K | +1.28% |
See BCAX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BCAX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BCAX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonBCAX — Frequently Asked Questions
Quick answers to the most common questions about buying BCAX stock.
How has BCAX stock performed recently?
BCAX returned +94.2% over the past year, beating its 5-year annualized CAGR of -0.3%. The stock trades above its 200-day moving average, confirming the uptrend.
What is BCAX's all-time high price?
Bicara Therapeutics Inc. Common Stock reached $28.09 on 2024-11-06. The 52-week high is $24.25. Current 1-year return of +94.2% places the stock closer to historical peaks.
Where can I download BCAX historical price data?
This page provides BCAX daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2024-2026, downloadable in CSV format.